Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Karnataka
Heatwave
Ramzan
Coronavirus Cases In India
COVID-19 Vaccination
Fuel Price Hike
COVID-19 Guidelines
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / New anti-COVID drug may cost up to Rs. 3,000: Report
India

New anti-COVID drug may cost up to Rs. 3,000: Report

New anti-COVID drug may cost up to Rs. 3,000: Report
Written by Saptak Datta
Dec 30, 2021, 03:52 pm 2 min read
New anti-COVID drug may cost up to Rs. 3,000: Report
Molnupiravir was recently granted emergency use authorization (EUA) by the Drugs Controller General of India (DCGI).

Molnupiravir, an antiviral medication, is projected to cost between Rs. 2,000 and Rs. 3,000 for a full treatment. The drug—created by Merck and Ridgeback-Biotherapeutics—was recently granted emergency use authorization by the Drugs Controller General of India (DCGI) for use among COVID-19 patients. Merck said earlier it plans to utilize a graded pricing structure based on the World Bank income criteria.

Context
Why does it matter?
  • Molnupiravir is the first oral antiviral treatment for COVID-19 to be approved.
  • Merck says the drug cuts hospitalizations and deaths by half in patients with early COVID-19 symptoms.
  • The development takes precedence with the emergence of the highly contagious Omicron variant of coronavirus.
  • Amid concerns of a third wave of COVID-19, experts predict coronavirus infections in India may rise soon.
Do you know?
Which Indian companies will be manufacturing the drug?

Molnupiravir will be manufactured by 13 Indian pharmaceutical companies, including Cipla, Torrent, Dr. Reddy's, Sun Pharma, Mylan, Natco, Hetero, and Optimus. "Stocks of molnupiravir are expected to reach us by January 3," Arihant Chemist Managing Director Rajesh Jain told The Economic Times.

Eligibility
Who will be eligible for molnupiravir?

Molnupiravir is not recommended for children under the age of 18. The medication is also not meant for COVID-19-infected individuals who need to be hospitalized immediately. It only helps prevent COVID-19 from progressing into severe disease in those with early symptoms. An 800 mg dose twice a day is recommended. It is not permitted to be consumed for more than five consecutive days.

Testing
Molnupiravir to undergo further testing

The 13 companies will test molnupiravir on 1,000 patients each to determine its safety as part of post-marketing surveillance (PMS), CNN-News18 reported. The DCGI reportedly expects the trial's data within three months. The companies will be required to submit data on the drug's effects and side-effects every three months. The latest data on patients being administered molnupiravir will also be shared with the companies.

Methodology
How does molnupiravir work?

Molnupiravir works by causing errors in the virus's reproduction mechanism, according to the UK drug regulatory agency. The treatment causes mutations to accumulate by deceiving the virus into incorporating its material into copies of viral RNA. This renders the virus unable to replicate. The medication is able to lessen the severity of the condition by keeping virus rates low in the body.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Saptak Datta
Saptak Datta
Twitter
Saptak Datta covers national and political news for NewsBytes. He has previously worked with Zenger News as a correspondent. Over a career spanning more than a year, his work has focused on international affairs and defense. He holds a Master’s degree in Journalism from the Symbiosis Institute of Media and Communication, Pune.
Latest
World Bank
Drugs Controller General of India
COVID-19
Omicron variant
Related
Latest
UN Chinese Language Day: Interesting facts about the Chinese language
UN Chinese Language Day: Interesting facts about the Chinese language Lifestyle
Apple working on HomePod with Apple TV functions and FaceTime
Apple working on HomePod with Apple TV functions and FaceTime Technology
5 upcoming movies of 'Minnal Murali' star Tovino Thomas
5 upcoming movies of 'Minnal Murali' star Tovino Thomas Entertainment
Realme Narzo 50A Prime spotted on Amazon, India launch imminent
Realme Narzo 50A Prime spotted on Amazon, India launch imminent Technology
5 critically-panned Hollywood films that earned good at box office
5 critically-panned Hollywood films that earned good at box office Entertainment
World Bank
How Taliban's foreign currency ban affects Afghanistan
How Taliban's foreign currency ban affects Afghanistan World
Afghanistan: Biden says he's sticking to August 31 withdrawal deadline
Afghanistan: Biden says he's sticking to August 31 withdrawal deadline World
COVID-induced economic slowdown caused 1 lakh infant deaths in India
COVID-induced economic slowdown caused 1 lakh infant deaths in India World
World Bank deployed $157bn in 15 months to fight COVID-19
World Bank deployed $157bn in 15 months to fight COVID-19 World
What Nobel laureate Joseph Stiglitz said about India's COVID-19 fight
What Nobel laureate Joseph Stiglitz said about India's COVID-19 fight India
More News
Drugs Controller General of India
Corbevax gets approval for use in children aged 12-18 years
Corbevax gets approval for use in children aged 12-18 years India
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
COVID-19 vaccine Corbevax's samples cleared by India's apex testing laboratory
COVID-19 vaccine Corbevax's samples cleared by India's apex testing laboratory India
J&J vaccine's 1cr doses ready for export after CDL nod
J&J vaccine's 1cr doses ready for export after CDL nod India
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine India
More News
COVID-19
IPL 2022: Mumbai to host DC-PBKS fixture instead of Pune
IPL 2022: Mumbai to host DC-PBKS fixture instead of Pune Sports
COVID-19: India reports 1,247 new cases, one death
COVID-19: India reports 1,247 new cases, one death India
UP: Wearing masks now mandatory in Lucknow, 6 NCR districts
UP: Wearing masks now mandatory in Lucknow, 6 NCR districts India
COVID-19: India logs 2,183 new cases, 214 more deaths
COVID-19: India logs 2,183 new cases, 214 more deaths India
IPL 2022: Delhi Capitals squad undergoes quarantine following COVID-19 scare
IPL 2022: Delhi Capitals squad undergoes quarantine following COVID-19 scare Sports
More News
Omicron variant
COVID-19: India reports 949 new cases, 6 more deaths
COVID-19: India reports 949 new cases, 6 more deaths India
COVID-19: India logs 1,109 new cases, 43 more deaths
COVID-19: India logs 1,109 new cases, 43 more deaths India
COVID-19: India logs 1,086 new cases, 71 more deaths
COVID-19: India logs 1,086 new cases, 71 more deaths India
COVID-19: India reports 795 new cases, 58 more deaths
COVID-19: India reports 795 new cases, 58 more deaths India
COVID-19: China fighting worst outbreak, UK sets new high
COVID-19: China fighting worst outbreak, UK sets new high World
More News
Related
Jaguar launches F-PACE 300 Sport, 400 Sport with inline-six engines
Jaguar launches F-PACE 300 Sport, 400 Sport with inline-six engines Auto
IPL 2022: PBKS hand MI a fifth successive defeat
IPL 2022: PBKS hand MI a fifth successive defeat Sports
Decoding Rashid Khan's performance versus Jos Buttler in IPL
Decoding Rashid Khan's performance versus Jos Buttler in IPL Sports
Will Digvijaya Singh be arrested over Khargone violence remarks?
Will Digvijaya Singh be arrested over Khargone violence remarks? Politics
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022